New York City’s longest-standing Alzheimer’s event helped to bring attention to the growing need for care and resources for those impacted by Alzheimer’s and related dementias

NEW YORK, Oct. 24, 2024 — CaringKind, New York City’s leading expert in Alzheimer’s and related dementia caregiving, held their 36^th annual New York City Alzheimer’s Walk and Brain Health Day on Saturday, October 19^th at Central Park’s Naumburg Bandshell. The non-profit organization raised over $550,000 in support of individuals, families, and caregivers affected by Alzheimer’s and related dementias.

The event kicked off at 10AM with a diverse range of activities that contribute to cognitive wellness including hearing checks by an audiologist, a Healthy Well-Being Station courtesy of Eisai, farm-fresh produce from the Farmers Market, Family Fun Zone and Paw Therapy Hub, and CaringKind’s DREAM LOUNGE, which is an extension of their Early-Stage Center, providing a safe space for peer-to-peer connection among those living with memory loss. Prior to the Opening Ceremony, attendees also watched performances by the Blue Angel Dancers, Flash Mob Dancers, and Chinese Lion Dancers.

Prominent news anchors and longtime supporters of CaringKind, ABC7’s Bill Ritter and Mike Marza served as the Master of Ceremonies. They introduced community leaders on stage including Board Members Jeff Jones, Linda LaGorga and Joe Fisher, President and CEO of CaringKind Eleonora Tornatore-Mikesh, and Senator Cordell Cleare. Walk Chairs Todd Matlovsky and Townsend Davis, and Sheila Gray also shared their personal caregiving stories.

During the ceremony, CaringKind also honored two renowned leaders with awards for their contributions to the Alzheimer’s community including:

• Building Awareness Award: Vicki Schneps of Schneps Media for championing brain health awareness.
• Family Caregiver Award: Late State Senator Bill Perkins for his impactful work in advancing community well-being in Harlem and his advocacy for dementia rights. The Senator’s wife, Pamela Perkins received the award in his honor.

The 2-mile scenic walk began at 12PM through Central Park’s fall beauty which offered the perfect backdrop for walkers to honor their loved ones and raise funds for critical programs.

A variety of esteemed sponsors joined forces to make this powerful event a success including Eisai, Lilly, Bloomberg Philanthropies, The Patricof Family, Primetime Partners, Axsome, United Federation of Teachers, The 80^th Street Residence, CARITH, The Carmelite System, Attending Home Care, CAIPA, Coterie, Dystel, Goderich & Bourret LLC, Greycroft, Grimaldi Yeung Law Group, Sunrise Senior Living, The Watermark at Brooklyn Heights, Frank E. Campbell, The Funeral Chapel, Homecrest Community Services, Littman Krooks LLP, NY Connects, Aliviado, The Bristal Assisted Living & 305 West End Assisted Living, Holistic HomeCare Associates, Home Instead, MJHS Health System & MJHS Isabella Center for Rehabilitation and Nursing Care, Mutual of America Financial Group, Pitta & Baione LLP, Richmond Behavioral Associates, RiverSpring Living, and Brooklyn Roasting Company.

CaringKind’s mission is to create, deliver, and promote comprehensive and compassionate care and support services for individuals and families affected by Alzheimer’s and related dementia, and to eliminate Alzheimer’s disease through the advancement of research. To achieve their mission, CaringKind offers programs for individuals with dementia, their families, and professional caregivers. The non-profit is committed to generating public awareness, collaborating with research centers, and informing public policy through advocacy. 

To learn more about CaringKind, please visit https://caringkindnyc.org/.

About CaringKind:

CaringKind is your leading expert on Alzheimer’s and dementia caregiving. With over 45 years of experience, CaringKind works directly with community partners to develop the information, tools, and training to support individuals and families affected by dementia. CaringKind is dedicated to being your Trusted Partner in the journey through Alzheimer’s and related dementia care, providing guidance, support, and comprehensive services to every person, at every stage of the disease. From the moment of diagnosis to end-of-life care, their mission is to ensure that everyone, regardless of their background or the challenges they face, receive the Trusted Support they need, ensuring no one walks this path alone.

MEDIA CONTACT:
[email protected]

SOURCE CaringKind

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

“Hurricanes Helene and Milton were a stark reminder of the impact that climate change and major storms can have on our electrical grids,” said Corey Capasso, CEO of Urbint. “This strategic investment from S2G will enable us to provide a broader offering of storm response solutions to utilities, helping them to restore power faster and save lives in the process.”

Urbint for Storm Response is a centralized platform for managing the entire storm and natural disaster response process – from handling logistics, to managing emergency work, to allocating resources in real-time. With Urbint, utilities secure contractors faster, manage crew lodging and meals better, use response dollars more efficiently, and shorten restoration times.

“As we have seen in recent months, the higher frequency and intensity of storms poses a significant threat to our energy infrastructure. Our view is that resiliency against extreme weather events is of the utmost importance for utilities and there is a strong urgency to invest in mitigation and adaptation measures,” said Bala Nagarajan, managing director of S2G’s Energy Investment team. “Urbint’s software offers utilities the ability to adapt to climate change while improving grid uptime and safety. We believe that Urbint is poised to play a pivotal role in transforming how utilities manage risk and battle climate change.”

Urbint’s AI-powered risk mitigation solutions enable utilities to identify threats and target their resources to prevent incidents and improve safety and reliability. Many of the largest utilities in the country, including Southern Company, Exelon, and National Grid, trust Urbint to help them protect underground infrastructure, prevent serious injuries and fatalities, and respond to and restore power faster after major weather events.

Learn more at Urbint.com.

About Urbint
Urbint uses AI and the latest industry science to identify threats to workers and infrastructure to stop safety incidents before they happen. Urbint surfaces risk at the point of work, enabling energy and infrastructure companies to prevent worker injuries and asset damages. Many of the largest energy and infrastructure companies in North America trust Urbint to protect workers, assets, communities, and the environment.

About S2G Ventures
S2G is a multi-stage investment firm focused on venture and growth-stage businesses across food and agriculture, oceans and energy. The firm provides capital and value-added resources to entrepreneurs and leadership teams pursuing innovative market-based solutions that S2G believes are cheaper, faster or better than traditional alternatives. With a commitment to creating long-term, measurable outcomes, S2G structures flexible capital solutions that can range from seed and venture funding through growth equity to debt and infrastructure financing. For more information about S2G, visit s2gventures.com or connect with us on LinkedIn.

SOURCE Urbint

There are 3 million inside sales reps in the US. Their primary goals are to generate a “pipeline” of deals and then “close” those deals to produce revenue. But low-leverage activities involved in pipeline generation like online research, writing prospecting emails, and dialing their contacts consume the time they could spend on more strategic selling. Now, Nooks can automate these time-consuming activities and free reps to do human-centered, strategic work that generates many times more pipeline than they possibly could before.

“There’s a camp of sales leaders who don’t believe in AI and want to stick with old-school methods. And there’s a newer camp who believe AI will completely replace sales reps.

Nooks is somewhere in the middle,” Dan Lee, CEO of Nooks. “We believe sales is fundamentally human and AI will empower reps—not replace them. We’re building AI assistants to automate the busywork in pipeline generation so humans focus on the human parts of selling.”

Introducing Nooks AI Sales Assistant Platform (ASAP)
Nooks is an AI platform that helps sales teams generate pipeline more efficiently by automating time-consuming tasks. Nooks users typically include sales development representatives (SDRs) and account executives (AEs) who self-source deals, as well as sales leaders, sales enablement, and revenue operations. Sales orgs typically see 2-3x pipeline generation per rep within days of adopting the platform.

Nooks’ AI assistants include:

• The AI Dialing Assistant helps teams have more quality conversations with prospects. It finds phone numbers, skips answering machines, leaves voicemails, does your pre-call research, and takes notes. It even suggests who you should call and when you should call them. Most teams using Nooks see 2-3x increase in call volume and conversations.
• The AI Coaching Assistant helps reduce ramp times and increase conversion rates. It transcribes and scores calls to understand areas to improve, and prepares reps for real-world selling via AI that simulates conversations with your prospects. It also has a Virtual Salesfloor to help remote and hybrid teams work and train together.
• The AI Prospecting Assistant eliminates time spent doing research online and switching between dozens of data tools. It researches your target accounts, identifies buying signals, builds lists of prospects, and drafts emails to them.

Nooks integrates with popular sales tools like Outreach, Salesloft, Gong, Hubspot and Salesforce. It also has integrations with data tools like Apollo, ZoomInfo, Cognism, LeadIQ, and more. These partnerships help deliver faster ROI by integrating with customers’ various go-to-market systems.

Customer Traction & Momentum
This announcement comes on the heels of significant momentum for Nooks. The company just recently announced its $22M Series A in April. Nooks has also experienced continued 4x YoY revenue growth.

“Nooks is bringing AI to the sales process in a human way—enabling sales teams with AI assistants,” Mamoon Hamid, Partner, Kleiner Perkins. “Their approach is already empowering thousands of sales reps, and Dan and team have demonstrated that they have both the vision and acumen to build a generational company.”

World-class organizations like Seismic, Fivetran, Amplitude, Modern Health, and Verkada rely on Nooks to power their sales teams. Customers typically attribute more than 70 percent of their sales pipeline to Nooks.

“If your sales team isn’t using an AI assistant platform like Nooks today, you should be worried about hitting your 2025 targets,” said Alyson Watson, CEO of Modern Health. “Nooks helps drive over 70 percent of our sourced pipeline. And my reps love Nooks. They’d quit if we got rid of it.”

To learn more about Nooks or get a free trial, visit Nooks.ai

About Nooks
Nooks is the AI Sales Assistant Platform (ASAP) that automates the busywork so reps can focus on the human part of selling and generate more sales pipeline. Nooks has helped thousands of sales reps hit quota, saved customers hundreds of thousands of hours, and powered hundreds of millions of dollars in pipeline. For more information, visit Nooks.ai. To review open positions across product, engineering, and go-to-market, visit Nooks.ai/careers

SOURCE Nooks

Startup launches new products designed to provide unique solutions and accelerate AI adoption

CAMPBELL, Calif., Oct. 24, 2024 — Zencoder, a pioneering AI startup focused on enhancing software development, today announced its emergence from stealth mode and the release of a suite of new products that will enhance developers’ use of generative AI. Zencoder has been quietly gaining traction within the developer space, having opened an alpha for its platform in June and has over 500 interested companies on their waitlist. In addition to the new products, Zendcoder’s coding platform will be generally available as of today for developers.

Founded in 2023 by serial entrepreneur Andrew Filev, Zencoder’s AI platform and coding agents integrate seamlessly into development workflows, offering intelligent code generation, code repair, test generation, and real-time optimization. Filev’s extensive experience in developing work management solutions at scale is the driving force behind Zencoder’s innovative approach. Thanks to his success at Wrike (acquired by Citrix for $2.25B in 2021), Filev assembled a team of top-tier AI experts and developers to create industry-leading products that are both powerful and user-friendly.

“At Zencoder, we believe in empowering developers with the tools they need to build the future,” said Andrew Filev, Founder & CEO of Zencoder. “Our AI coding agents are designed to bring zen back into coding by handling the mundane tasks, so developers can unleash their creativity and continue to iterate on solving real-world challenges.”

Introducing: Embedded AI Agents for Developers
While generative AI revolutionized content creation in many areas, its impact on software development has been slower, with developers still struggling to balance innovation and routine tasks like maintenance and bug fixing. Early AI coding assistants, with occasional LLM hallucinations and incorrect code generation, haven’t provided a comprehensive solution, slowing the adoption of AI.

Zencoder remedies this by building a more comprehensive, compound AI system relying on agentic workflows integrated with static code analysis. Zencoder’s proprietary and robust AI products significantly reduce the hallucinations that are prevalent with current AI assistants on the market and integrate seamlessly with IDE’s making adoption frictionless for developers. Zencoder’s primary technology pillars include:

• Repo Grokking™ – deeply analyzes the entire code repository, providing crucial context that significantly improves the relevance and quality of AI-generated code. This enables intelligent code generation, context-aware code completion, code refactoring and docstring generation among other features.
• Agentic Repair™ – pipeline that automatically analyzes, fixes, and refines generated code, further improving it and ensuring higher quality and reliability. This enables the generation of the highest quality code with code repair and unit test generation agents.
• Agentic Loop™ – brings planning and feedback to amplify the power of underlying models. This enables the agents to automate multi-step processes with self-reasoning.

These pillars power both traditional coding assistance features like AI chat and code completion as well as powerful coding agents that undertake common engineering activities of bug fixing, refactoring, new feature development, and writing unit tests. Zencoder also allows customers to define their own custom agents to automate mundane tasks.

This approach integrates cutting-edge AI research with deep software engineering and user-centric design, ultimately empowering companies to ship software products faster and more efficiently.

Zencoder’s AI Agents allows developers to:

• Boost Productivity: Automate repetitive coding tasks and streamline complex workflows, enabling developers to focus on high-value problem-solving and innovation.
• Enhance Code Quality: Minimize errors and improve code reliability with AI-driven error correction.
• Accelerate Development Cycles: Reduce time-to-market for software products by speeding up the coding and testing phases.

For more information on Zencoder and access to the waitlist, please visit: www.zencoder.ai.

Zencoder Participating at TechCrunch Startup Battlefield 2024
Zencoder recently announced its selection for TechCrunch Startup Battlefield 2024. Out of thousands of applicants, Zencoder was chosen to showcase its innovation at TechCrunch Disrupt (Oct. 28-30), placing it among the top data-driven AI startups in the industry.

About Zencoder
Zencoder is a pioneering AI startup focused on enhancing the software development process through embedded AI coding agents. Founded by industry veteran Andrew Filev with a passion for innovation, Zencoder aims to make coding more efficient, accurate, and enjoyable for developers worldwide. Zencoder has a team of 50+ AI experts, engineers, and data scientists across the globe.

For more information, please visit www.zencoder.ai or contact: Archie Sharma, COO GTM
Media contact: [email protected]

SOURCE Zencoder

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

NEW YORK, Oct. 24, 2024 — Attention, the platform that transforms customer conversations into actionable insights, announced today its $14 million Series A funding to power its next phase of growth. The investment was led by Alven, with participation from Eniac, 645 Ventures, Aglae, Frst, and Liquid2. The funding highlights the growing demand for Attention’s AI product and solutions as the business saw a 10x revenue increase this year, with customers including Crunchbase, BambooHR, Aircall, and Clay amongst others.

Founded by repeat entrepreneurs and former competitors, Anis Bennaceur and Matthias Wickenburg, Attention addresses a critical need in the market: enabling revenue teams to unlock and utilize the valuable data hidden in customer interactions. Traditional methods of capturing and analyzing this data are expensive, error-prone, and incomplete. Attention automates this process, offering sales teams a powerful tool to close more deals using the voice of the customer.

“Automating CRM entry out of customer conversations and writing follow-up emails was just the beginning. There is so much more to do out of these precious interactions,” said Bennaceur, Co-Founder and CEO of Attention.

Attention will use the new funding to fulfill strong market demand and expand its go-to-market team, while continuing to invest in product and engineering to solidify its leadership in the AI-driven sales market – a category it pioneered.Attention’s long-term vision is ambitious: to fully automate the routine tasks handled by revenue and sales teams, enabling them to focus on more strategic activities.

“We have built a system of cognition that continuously learns and improves, delivering better results over time,” said Wickenburg, Co-Founder and CTO of Attention. “We believe that our technology will not only enhance jobs but also redefine them, making sales teams more efficient and effective than ever.”

Thomas Cuvelier, General Partner at lead investor Alven, who has also backed transformative AI unicorns such as Dataiku and Algolia, added: “Attention’s Generative AI native capabilities are a paradigm shift to a system of cognition for the revenue function – they can effectively clone top performers by extracting features out of successful sales deals while at the same time dramatically enhance productivity. Anis and Matthias have an exceptional eye for product, and have built a compelling proposition in what is a very large, fast-growing, and dynamic market.”

Austin Myers, VP Revenue at Certificial and Attention customer shared, “Thanks to Attention, our sales pipeline velocity has skyrocketed. With automated CRM entry and insightful scorecards, deals progress smoothly, leading to quicker conversions. It’s streamlined our processes and turbocharged our revenue growth.”

This round of funding marks a pivotal chapter in Attention’s growth story. With a robust foundation, a clear strategic direction, and the support of world-class investors, the company is poised to make significant strides in revolutionizing sales enablement for businesses worldwide.

To get in touch with the Attention team, reach out at [email protected].

About Attention

Attention is a leading AI-powered platform dedicated to helping sales and revenue teams unlock the full potential of their customer conversations. By automating the extraction of actionable insights, Attention enables businesses to make informed decisions, enhance performance, and drive growth.

About Alven

Alven is an early-stage venture capital firm investing in world-class teams and products, and guiding entrepreneurs from seed to growth across the US and Europe. With over $2 billion under management, Alven has backed over 180 teams in the last two decades, including many success stories such as Stripe, Algolia, Dataiku, Qonto and Gorgias.

Photo – https://mma.prnewswire.com/media/2538940/Attention__Anis_Bennaceur_CEO_and_Matthias_Wickenburg_CTO.jpg

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

HALIFAX, NS, Oct. 24, 2024 – Planetary Technologies, a leader in ocean-based climate solutions, has completed its Series A funding round, raising $11.35 million USD.

Led by Evok Innovations, the round includes new investors BDC Capital, Amplify Capital, DNX Ventures, and Iconiq Capital. These funds will support Planetary’s mission to enhance the ocean’s natural ability to fight climate change through carbon removal and storage.

“We’re most excited by the strong alignment that these investors have with our mission,” said Mike Kelland, CEO of Planetary Technologies. “This round enables us to continue leading the way on responsible, science-led development of a critical climate technology. Together, we are building a foundation that will allow us to achieve our vision of protecting and restoring both the ocean and climate for generations.”

Scaling Planetary’s Vision to Protect the Oceans and the Climate

Planetary Technologies uses ocean alkalinity enhancement (OAE) to remove carbon dioxide from the atmosphere. Roughly 25% of CO₂ emissions dissolve into the ocean, increasing acidity. Planetary’s process restores coastal environments, helping the ocean remove carbon more efficiently. This method mimics natural processes that have regulated atmospheric CO₂ for millions of years.

The new funding will allow Planetary to expand pilot projects, scale operations, and further demonstrate the safety and effectiveness of its technology. The company will continue collaborating with local communities, academic institutions, and regulatory bodies to ensure its solutions are both scientifically sound and sustainable.

“Evok Innovations is pleased to support Planetary Technologies in their mission to combat climate change through ocean-based solutions,” says Jane Kearns, Partner at Evok Innovations. “Planetary’s approach, rooted in science and community engagement, represents a significant step toward enhancing marine remediation & natural carbon removal processes. Evok values the Planetary team’s commitment to innovation and collaboration with local stakeholders, researchers and academic institutions, and we are excited to support their continued growth. We anticipate meaningful advancements in the near future, both for the company’s core business, and for marine carbon removal as a broader industry that will benefit from Planetary’s work”.

About Planetary Technologies

Planetary Technologies is a climate technology company focused on removing carbon through ocean alkalinity enhancement. By enhancing the ocean’s natural ability to absorb and store carbon, Planetary offers scalable solutions to climate change

SOURCE Planetary Technologies

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

Mr. Frohlich, formerly Chief Operating Officer of Chinook Therapeutics, brings 20+ years of leadership experience; Dr. Kocinsky offers deep expertise in developing therapies for autoimmune and kidney diseases

Board of Directors, comprised of industry veterans in science, business, and strategy, will support the company’s growth

Expanded financing to accelerate clinical development of Jade’s novel therapies targeting autoimmune diseases with significant unmet need

VANCOUVER, BC and SAN FRANCISCO, Oct. 24, 2024 — Jade Biosciences, Inc. (“Jade”), a biotechnology company dedicated to developing best-in-class therapies for patients living with autoimmune diseases, today announced the appointment of Tom Frohlich as Chief Executive Officer (CEO) and Hetal Kocinsky, M.D., as Chief Medical Officer (CMO). The company also introduced its newly formed Board of Directors, marking a significant step in the company’s growth trajectory.

Jade has extended its financing, bringing the total raised to $95 million. The financing round adds Frazier Life Sciences and Versant Ventures to an investor syndicate that includes Fairmount, Venrock Healthcare Capital Partners, Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, and Braidwell LP.

Strategic Appointments to Lead Jade’s Next Growth Phase

Tom Frohlich, Chief Executive Officer

Mr. Frohlich, a biotech and pharma industry veteran, brings over 20 years of experience in company building, business strategy, and product development. Before joining Jade, he co-founded and served as Chief Operating Officer (COO) of Chinook Therapeutics, where he guided the company’s growth through to its $3.2 billion acquisition by Novartis in 2023. He also held leadership roles at Arbutus Biopharma, Johnson & Johnson, and Merck, managing key areas such as commercial strategy and business development.

“I am honored to join Jade Biosciences and lead this talented team through such an exciting time,” said Frohlich. “With a strong balance sheet, world-class investors, and an experienced leadership team, we are well-positioned to advance therapies that will transform patient care in autoimmune diseases.”

Hetal Kocinsky, M.D., Chief Medical Officer

Dr. Kocinsky brings deep expertise in drug development, having led clinical programs from early-stage research to regulatory approvals across multiple therapeutic areas. Most recently, she served as Vice President of Translational Medicine at Chinook and held leadership roles at Apellis and Achillion Pharmaceuticals. A board-certified pediatric nephrologist, she also spent time as an Assistant Professor at the Yale School of Medicine.

“I look forward to working alongside the team at Jade in our quest to deliver breakthrough therapies to patients in need,” said Dr. Kocinsky. “With my background in translational medicine and experience navigating complex clinical landscapes, I look forward to accelerating solutions that can redefine care for patients with autoimmune diseases.”

New Board of Directors Brings Industry Expertise and Strategic Insight

Jade’s newly formed Board of Directors is led by Board Chairman Eric Dobmeier, former President and CEO of Chinook Therapeutics, and brings together industry leaders with expertise across science, business operations, and corporate strategy. The board includes:

• Chris Cain, Ph.D. – Director of Research, Fairmount Funds Management LLC
• Eric Dobmeier – Board Chairman, Venture Partner, Samsara BioCapital
• Tom Frohlich – CEO, Jade Biosciences
• Tomas Kiselak – Managing Member, Fairmount Funds Management LLC
• Lawrence Klein, Ph.D. – CEO of Oruka Therapeutics
• Erin Lavelle – Former COO and CFO at Profound Bio, Eliem Therapeutics; additional leadership roles at Alder BioPharmaceuticals and Amgen

About Jade Biosciences

Jade Biosciences is developing transformative therapies with the goal of redefining the standard of care for autoimmune diseases. The company launched in July 2024 and has raised $95 million from a strong slate of investors: Fairmount, Venrock Healthcare Capital Partners, Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, Braidwell LP, Frazier Life Sciences, and Versant Ventures. Jade’s portfolio was engineered by Paragon Therapeutics. For more information, visit JadeBiosciences.com and follow us on LinkedIn.

Media Contact

[email protected]

SOURCE Jade Biosciences

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

Newly-unveiled startup to speed up biotech and drug development

NEWTON, Mass., Oct. 24, 2024 — Dash Bio, an innovator in tech-enabled services for drug development, announced today that it has raised $6.5M in seed financing. The round was led by Freestyle Capital, with participation from Swift Ventures, LifeX Ventures, and other private investors.

Despite tremendous innovation in biotech research over the past decade – from pioneering applications of AI to major breakthroughs in mRNA and CRISPR – drug development remains slow and expensive, with new drugs costing an average of $6.7 billion and taking 12 years to get from concept to launch. That lag is driven by manual processes and legacy systems, which dramatically reduce the efficiency of clinical development and the effectiveness of the industry overall.

“Development is broken in biotech today, and we all pay the price,” says Dave Johnson, CEO and co-founder of Dash Bio and former Chief Data & AI Officer at Moderna. “We founded Dash Bio to ensure that groundbreaking medicines reach those who need them — faster.”

Now out of stealth, Dash Bio takes a technology-first approach to developing critical services across the drug development lifecycle. The company is building new capabilities that leverage AI, robotics, and fully-integrated software to fundamentally reinvent the way drugs are brought to market. Their first capability is a highly-automated clinical bioanalysis lab that promises to deliver GLP-compliant services with unprecedented speed.

Dash Bio’s founding team draws from a deep well of knowledge in this space. Founders include Dave Johnson (CEO), former Chief Data & AI Officer at Moderna; Ander Tallett (COO), CEO and founder of DigitalRadius and an experienced executive with stints at Moderna and Science Exchange; and Ely Porter, CTO and co-founder of Rootpath, a pioneer in synthetic immunology and gene synthesis.

“With the advancements of AI and quantum among other technologies, we are seeing huge advancements in drug discovery and expect that only to continue, but feel that the path from discovery through development to make drugs patient ready is still very antiquated and untouched by technology. We knew this was the team to tackle that challenge and you rarely find a team as deep in both AI and bio as this founding team,” says Maria Palma, General Partner at Freestyle Capital.

“We’re living through a golden age of biotech and drug discovery, but the reality is that the process for getting a drug to market threatens to slow progress. Dash Bio promises a new era of faster clinical drug development that meets the moment,” notes Brett Wilson, General Partner at Swift Ventures.

About Dash Bio
Dash Bio is rebuilding drug development from the ground up by leveraging AI, robotics, and fully-integrated software to fundamentally reinvent the way drugs are brought to market. Learn more at dash.bio.

SOURCE Dash Bio

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

NEW YORK, Oct. 24, 2024 — Sociaaal, the fast-growing mobile app studio that specializes in building, buying, and publishing non-gaming apps for Gen Z, is pleased to announce it has secured $4 million in financing from Braavo Capital. The funding will be used to focus on expanding their publishing unit to further scale the business, acquire more apps, and enhance marketing for their existing portfolio.

Founded in 2022, Sociaaal has quickly become a market leader with a portfolio of 20 apps and over 34 million downloads. With a focus on rapid app development, data-driven strategies, and refined user acquisition capabilities, Sociaaal successfully launches and monetizes new apps in less than one month. The company capitalizes on Gen Z’s demand for apps that deliver quick but meaningful and fun interactions, with apps like Litstick, which offers short, engaging content in the form of prank stickers.

This round of funding from Braavo Capital positions Sociaaal for further expansion, with the goal of doubling their size within the next year. The company also has plans to expand beyond social and entertainment apps into new categories like self-improvement, productivity, and wellbeing, already demonstrated by products like its AI-powered Dreamwise app that allows users to record and analyze their dreams.

“We are impressed with Sociaaal’s growth and are thrilled to lead this financing round,” says Mark Loranger, CEO of Braavo Capital. “Braavo’s $4 million commitment demonstrates our belief in their team’s vision and ability to execute.”

Sociaaal CEO Patrick Stuart-Constant reiterated the sentiment, “Braavo has been an invaluable partner throughout Sociaaal’s growth journey, and was a natural fit for this round of financing. Their ability to quickly understand Sociaaal’s growth potential made them an ideal partner for this critical phase of expansion.”

About Sociaaal

Founded in 2022, Sociaaal is the fast-growing mobile app studio that specializes in building, buying, and publishing non-gaming apps for Gen Z . The company has leveraged its expertise in rapid iteration, AI, and data driven strategies to reach over 34 million installs across its portfolio of 20 apps.

About Braavo Capital

Established in 2015, Braavo is the leading funding partner for the world’s most successful app businesses. Having facilitated over $1 billion in financing and supported over 8000 apps since inception, Braavo offers a range of financing, from on-demand receivables to multi-million dollar bespoke credit facilities.

SOURCE Sociaaal

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In